Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study of the Efficacy of the Ophthalmic Emulsion PRO-145 for the Management of Inflammation and Pain After Phacoemulsification Compared to Prednisolone Acetate 1%.

NCT03693989 is registered in ClinicalTrials.gov with Laboratorios Sophia S.A de C.V. as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03693989 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study of the Efficacy of the Ophthalmic Emulsion PRO-145 for the Management of Inflammation and Pain After Phacoemulsification Compared to Prednisolone Acetate 1%.
Lead sponsor
Laboratorios Sophia S.A de C.V.
Phase
Phase 3
Overall status
Completed
Start date
October 4, 2018
Completion date
October 22, 2019
Enrollment
178 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.